'Neutralizing antibodies' diaporamas de présentation

Dale and Betty Bumpers Vaccine Research Center

Dale and Betty Bumpers Vaccine Research Center National Institute of Allergy and Infectious Diseases National Institutes of Health Department of Health and Human Services. HIV Vaccine Enterprise: Progress in Basic Research. International AIDS Vaccine Meeting 2010 Atlanta, GA.

725 views • 56 slides

Homework # 2

Homework # 2. A2 Subsection Dr. Sandra Navarra USTFMS. 1. List the elements of the immune response to HIV and give an example of each element. Elements of the Immune Response to HIV. Humoral immunity. Cell-mediated immunity. Helper CD4 T lymphocytes

648 views • 52 slides

Porcine Respiratory and Reproductive Syndrome

Porcine Respiratory and Reproductive Syndrome. Dr. Alex Ramirez Veterinary Diagnostic and Production Animal Medicine Iowa State University. General Overview. PRRS. THE most $$$ significant disease of swine $560 million / year ? $5.60 / pig marketed 1 Comparison PRV $36 million / year

1.04k views • 42 slides

precedence

precedence. 1. the condition of preceding others in importance, order or rank 2. an acknowledged or legally determined right to such precedence. Clinical trials take precedence for vaccine development at the current time: yes or no?.

619 views • 41 slides

DENGUE: EPIDEMIOLOGY PART 1

DENGUE: EPIDEMIOLOGY PART 1. SCOTT B HALSTEAD, MD. Director, Research PEDIATRIC DENGUE VACCINE INITIATIVE. TRANSMISSION. Aedes aegypti breeds in clean water in and around houses. Daytime biting.

521 views • 40 slides

Dr Penny Moore

C APRISA. CENTRE FOR THE AIDS PROGRAMME OF RESEARCH IN SOUTH AFRICA. CAPRISA is a UNAIDS Collaborating Centre for HIV Prevention Research. Characterization of acute infection in South Africa and its relevance to HIV vaccine discovery - focus on neutralizing antibodies. Dr Penny Moore.

458 views • 26 slides

Neutralizing Antibody Assays for HIV-1, SIV and SHIV: Recent Advances in Technology

Neutralizing Antibody Assays for HIV-1, SIV and SHIV: Recent Advances in Technology. David C. Montefiori, Ph.D. Laboratory for AIDS Vaccine Research & Development Duke University Medical Center Durham, NC monte@duke.edu.

1.03k views • 22 slides

Methods and Logic 2007 Inhibitors

522 views • 13 slides